Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells

Melodie L Knowlton1, Laura M Selfors, Carolyn N Wrobel

  • 1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|November 5, 2010
PubMed

Insights

This study identifies new SRC-dependent substrates activated by receptor tyrosine kinases (RTKs) using quantitative mass spectrometry. These findings reveal novel signaling pathways and potential cancer biomarkers for SRC activation in tumors.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Receptor tyrosine kinases (RTKs) initiate signaling cascades by activating downstream kinases.
  • SRC family kinases (SFKs) are key mediators recruited to activated RTKs.
  • A systematic analysis of receptor-activated SFK substrates was lacking.

Purpose of the Study:

  • To systematically identify downstream substrates of SFKs activated by the CSF-1R tyrosine kinase.
  • To characterize novel tyrosine phosphorylation changes induced by CSF-1R.
  • To discover candidate markers of SRC activation in human cancers.

Main Methods:

  • Quantitative mass spectrometry utilizing stable isotope labeling (SILAC).
  • Comparison of phosphotyrosine peptides from cells expressing CSF-1R versus a mutant lacking SFK binding.
  • Analysis of phosphoproteomic data from breast and lung cancer patient samples.

Main Results:

  • Identified uncharacterized tyrosine phosphorylation changes induced by CSF-1R.
  • Discovered a set of candidate SFK substrates dependent on SRC recruitment to CSF-1R.
  • Found that many candidate substrates possess phosphorylation motifs characteristic of SRC kinase targets.
  • Detected a subset of SRC-dependent phosphorylation sites correlated with SRC activation in cancer patient samples.

Conclusions:

  • Quantitative, site-specific tyrosine phosphorylation changes induced by CSF-1R activation in epithelial cells were revealed.
  • Numerous candidate SRC-dependent substrates phosphorylated downstream of an RTK were identified.
  • These findings provide insights into RTK-SFK signaling and identify potential biomarkers for SRC activation in human tumors.

Related Concept Videos